Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Feb;43(2):185-196.
doi: 10.1007/s40618-019-01099-2. Epub 2019 Aug 21.

A broad range of symptoms in allgrove syndrome: single center experience in Southeast Anatolia

Affiliations

A broad range of symptoms in allgrove syndrome: single center experience in Southeast Anatolia

R Polat et al. J Endocrinol Invest. 2020 Feb.

Abstract

Background: Allgrove syndrome (OMIM 231550) is a rare autosomal recessive disease characterized by non-CAH primary adrenal insufficiency (non-CAH PAI), alacrima, and achalasia. It is caused by mutations in the AAAS gene. The syndrome is also associated with variable progressive neurological impairment and dermatological abnormalities.

Methods and results: We diagnosed 23 patients from 14 families with Allgrove syndrome, based on the presence of at least two characteristic symptoms, usually adrenal insufficiency and alacrima, between 2008 and 2018. A previously described nonsense variant of AAAS was detected in 19 patients from 12 families at homozygous state. Another novel homozygous mutation (c.394-397delCTGT) in AAAS was detected in four patients from two families. Presenting symptoms were alacrima (23/23; 100%), adrenal insufficiency (18/23; 78%), achalasia (13/23; 57%), short stature/growth retardation (16/23; 70%), hyperreflexia (15/23; 65%), palmoplantar hyperkeratosis (13/23; 57%), hyperpigmentation of the skin (10/23; 43%), hypoglycemia-induced convulsion (7/23; 30%), swallowing difficulty and vomiting (6/23; 26%). Serum DHEAS concentrations were low in all patients (23/23; 100%).

Conclusions: Clinical symptoms vary even among patients carrying the same mutation. Triple A syndrome should be considered in the etiology of non-CAH PAI in Arab populations and in Southeast Turkey. Any child with non-CAH PAI should be evaluated for the presence of alacrima and/or achalasia or family history of alacrima and/or achalasia. Children with alacrima and/or achalasia should also be investigated for adrenal insufficiency. Definitive molecular diagnosis is essential for early diagnosis and management of adrenal insufficiency, neurological symptoms, and growth retardation in patients and early diagnosis of as yet asymptomatic cases in the family, together with genetic counseling.

Keywords: Achalasia; Adrenal insufficiency; Alacrima; Allgrove syndrome; Palmoplantar hyperkeratosis; Triple A syndrome.

PubMed Disclaimer

References

    1. Endocrinology. 2013 Sep;154(9):3209-18 - PubMed
    1. Eur J Med Res. 2003 Jul 31;8(7):318-20 - PubMed
    1. Korean J Pediatr. 2016 Nov;59(11):456-459 - PubMed
    1. Eur J Paediatr Dent. 2015 Dec;16(4):324-6 - PubMed
    1. Lancet. 1978 Jun 17;1(8077):1284-6 - PubMed

MeSH terms

Supplementary concepts

LinkOut - more resources